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Salmon farming in Norway relies on the protection
provided by multi-component vaccines, and this has
contributed both to the growth of the industry and its
relatively low level of antibiotic use compared to
other salmon farming regions (Love et al. 2020).
However, oil-adjuvanted vaccines induce abdominal
lesions and peritonitis (Midtlyng et al. 1996), lead to
short-term reductions in feed intake (Sørum & Dams-
gård 2004), and reduce growth by between 9 and 23%
post-vaccination (Midtlyng & Lilllehaug 1998, Fraser
et al. 2014). Furthermore, tissue-specific inflamma-
tion and systemic autoimmunity has been suggested
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ABSTRACT: Oil-adjuvanted vaccines reduce long-term growth in farmed Atlantic salmon Salmo
salar, possibly via an increase in metabolic rate due to the energetic demands of the immune sys-
tem. We tested this hypothesis by comparing sham-vaccinated to vaccinated smolts (total n =
2096, ca. 80 g) under different scenarios of water temperature (12 vs. 17°C, n = 1048 per tempera-
ture) and oxygen (O2) saturation (60, 70, 80, and 100%, n = 524 per O2 saturation level) in order to
manipulate metabolic rate and O2 availability. We expected a more severe vaccination effect
under conditions of high water temperature and low O2 saturation. Groups were kept in duplicate
tanks under controlled temperature and hypoxia conditions for 7 wk post-vaccination before
being transferred to uncontrolled common-garden natural conditions for 5 mo in a sea-cage. Body
mass and length were recorded at the initiation and end of the controlled and uncontrolled envi-
ronmental conditions. Vaccination and low O2 saturation at 17°C significantly reduced body mass
(13 and 3% through vaccination and 9 and 20% through 60% O2 saturation at the end of the tank
and sea-cage periods, respectively). However, there was no interaction between vaccination, tem-
perature, and O2 saturation at the end of the tank or sea-cage period, lending no support to our
hypothesis. A secondary observation was that emaciated ‘loser’ fish were mainly associated with
the 17°C and low (mainly 60%) O2 saturation treatment. In conclusion, although vaccination led to
a reduction in body mass, this effect was not influenced by environmental conditions expected to
alter metabolic rate.
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to be induced by multivalent oil-adjuvanted vaccines
(Koppang et al. 2008, Haugarvoll et al. 2010), and an
increased risk of skeletal deformities has been re -
ported (Berg et al. 2006). The adjuvants are neces-
sary in order to provide long-term protection due to
slow release of the antigens within the peritoneal
cavity, but the adjuvants are also related to the occur-
rence of many of the unwanted side effects (Midtlyng
et al. 1996). Although improvements have been made
in reducing the severity and frequency of vaccine
side effects, they still occur (Brudeseth et al. 2013).
The immune system is energetically demanding,
due to the metabolic requirement of immune cells, but
also through indirect consequences such as tissue
degradation or anorexia during inflammation (Loch -
miller & Deerenberg 2000). As oil-adjuvanted salmon
vaccines lead to a chronically active immune re sponse
that peaks at 6 mo post-vaccination (Mutoloki et al.
2004, 2006), one may suspect that the reduced growth
is a result of an increased metabolic cost of the im -
mune system. Indeed, several studies have found in-
creases in standard metabolic rate following vaccina-
tion in fish. For example, rainbow trout Oncorhynchus
mykiss vaccinated against Aeromonas salmonicida
(Ackerman et al. 2000) or with a DNA vaccine (Skinner
et al. 2010) have an increase in oxygen (O2) consump-
tion. In addition, Fraser et al. (2015) observed an in-
crease in heart size in vaccinated vs. unvaccinated
fish, which is suggestive of an increase in cardiac
workload that one may expect with an increase in
metabolic demand. Finally, an increase in abdominal
lesions in salmon vaccinated at what is considered
high (16°C) versus lower (10°C) water temperature
has also been observed (Grini et al. 2011). Here, as
factorial aerobic scope is known to be reduced with in-
creasing environmental temperature in salmon (Hvas
et al. 2017), one may speculate that higher than optimal
temperatures may reduce the amount of energy avail-
able to the immune system that is expected to be en-
ergy-demanding (Lochmiller & Deerenberg 2000).
Our main objective was to investigate whether
 vaccine-induced reduced growth could be related to
metabolic demands. Our hypothesis was that reduced
growth is due to an increase in metabolic demand
following vaccination. To this end, we manipulated
water temperature (to alter metabolic rate) and O2
saturation to produce various levels of metabolic lim-
itation in vaccinated and unvaccinated salmon. The
various environmental conditions, all combinations
of 12 vs. 17°C, and 60, 70, 80, and 100% O2 satura-
tion, were maintained for 1 mo following vaccination.
Water temperature is positively associated with
metabolic rate in salmon (Hvas et al. 2017), and the
ability to withstand hypoxia decreases exponentially
between 6 and 18°C (Remen et al. 2013). As such,
based on cyclic hypoxia studies, we expect ≤60% O2
saturation to be physiologically challenging at 17°C,
but not at 12°C (Remen et al. 2012, 2013). As a sec-
ondary objective, we also report on the long-term
effects of the environmental conditions and vaccina-
tion on growth and production characteristics (anti-
body production, ‘loser’ fish (hereafter referred to as
‘losers’), post-smolt maturation, cataracts, radiologi-
cal deformities) during 5 mo of common garden rear-
ing in a sea-cage.
2.  MATERIALS AND METHODS
2.1.  Fish stock and rearing conditions
Atlantic salmon Salmo salar from the Aquagen
strain were reared from first feeding (14 March 2016)
at the Institute of Marine Research (IMR) facilities at
Matre Research Station. Throughout, fish were fed
standard diets (Skretting) with an estimated 20%
surplus based on estimated growth. The tempera-
ture and photoperiod throughout the experiment
are summarized in Fig. 1. In brief, the temperatures
and photoperiods used prior to the study are com-
monly used to rear underyearling (i.e. 0+) smolts. As
such, a square wave photoperiod was used to initi-
ate smoltification. Prior to vaccination, the fish were
moved to 1 × 1 m tanks (n = 10) on 28 August 2016
(n = 2096 fish, mean weight 50 g, 10.5 kg m−3). Be -
tween 9 and 12 September 2016, the fish were im -
planted with a passive integrated transponder (PIT)
tag that allows for individual recognition and dis-
tributed among 16 tanks (1 × 1 m; n = 131 fish
tank−1). Between 3 and 10 October 2016, the experi-
mental conditions were set according to Table 1. On
10 October 2016, approximately half of the fish
(65−66 tank−1) were vaccinated with 0.1 ml AQUA-
VAC® PD7 vet. (MSD Animal Health, vaccine against
salmon pancreas disease virus, infectious pancreatic
necrosis virus, Aeromonas salmonicida subsp. sal -
mon icida, Vibrio anguillarum serotype O1 and O2a,
V. salmonicida, and Moritella viscosa; further details
can be found online at www. felleskatalogen.no),
whilst the remaining fish received 0.1 ml of sterile
saline via an intra- peritoneal injection (i.e. unvacci-
nated controls) according to standard operating pro-
cedures (initial body size of each group can be
found in Fig. S1 in Supplement 1 at www. int-res.
com/ articles/ suppl/ q012 p327 _ supp/, for all supple-
mental figures). The vaccinated and unvaccinated
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fish were mixed in the same tanks (i.e. common gar-
den). The water flow into the tanks was switched to
seawater on 2 November 2016 for those fish reared
at 17°C, and on 10 November 2016 for those fish
reared at 12°C. The difference in seawater timing
was related to the number of degree-days (the sum
of the daily temperature) required for smoltification
to peak. Here, 350 degree-days after the end of the
winter signal are required to complete smoltification
(i.e. Handeland et al. 2004). On 30 November 2016,
all fish were transferred to a single sea-cage (5 × 5 ×
7 m, stocking density of 1.2 kg m−3) for common-
garden rearing under natural temperatures and
light (60° N). Data from the control fish reared at
100% O2 saturation were previously reported in
another study detailing the oc currence of out-of-sea-
son post-smolt sexual maturation (Fraser et al. 2019a).
On 18 November, an unexplained mortality event
oc curred in 1 tank with 100% O2 from the 12°C
group, wherein 14 fish died. Of these,
50% were unvaccinated, so mortality
was not related to vaccination. A com-
parison of growth rates between this
tank and the second tank belonging to
this group showed no short- or long-
term differences in mean body mass;
therefore, these fish were included in
all of the analyses (data not shown,
but the models are given in Supple-
ment 2 at www. int-res. com/ articles/
suppl/ q012 p327 _ supp/).
2.2.  Sampling protocol
Body mass, fork length, and PIT tag number were
collected from all fish at 3 time points: 10 October
2016 (vaccination), 30 November 2016 (transfer to
sea-cage), and 26 April 2017 (end of seawinter, 28 wk
post-vaccination). At each sampling time, fish were
anaesthetised in 100 mg l−1 Finquel® (MS 222) prior
to handling. Gills (stored in RNA later for gene ex -
pression) and blood serum (for antibody assessment,
frozen at −80°C) were collected from 8−11 vaccinated
and 9−12 unvaccinated, terminally anaesthetised fish
from each of the 100, 80, 70, and 60% O2 groups (4−
6 fish group−1 tank−1) at 2, 4, and 6 wk post- vaccination,
and blood serum was also collected in Week 28 (on 26
April 2017). These time points were chosen to provide
good resolution in the development of smoltification
and the antibody re sponse. Here, all groups tested
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Fig. 1. Temperature (dots) and photoperiod (solid line) during the experiment. The grey zone represents the period of O2 satu-
ration (see Table 1) and temperature manipulation. Here, half of the fish were held at ~17°C (orange) and the other half at
~12°C (blue); otherwise, the fish were reared under a common temperature (grey dots). *Time of vaccination and **fish 
transferred to common-garden rearing within a sea-cage
Date                12°C groups                         17°C groups
                   Temp. Oxygen saturation (%)    Temp. Oxygen saturation (%)
                    (°C)        60     70     80    100         (°C)        60     70     80    100
03.10.2016    12        100   100   100   100           12        100   100   100   100
04.10.2016    12         80     80     80    100           12         80     80     80    100
05.10.2016    12         70     70     80    100           15         70     70     80    100
06.10.2016    12         60     70     80    100           15         60     70     80    100
07.10.2016    12         60     70     80    100           17         60     70     80    100
Table 1. Daily overview during the initiation of the environmental conditions
for Atlantic salmon reared under different controlled conditions of tempera-
ture and oxygen (O2) saturation
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(the 70% O2 groups were not included) were consid-
ered seawater-adapted at 4 (17°C groups) and 6 (12°C
groups) wk post-vaccination following gill gene expres-
sion analyses (Na+ K+ -ATPase isoforms α1a and α1b,
i.e. Houde et al. 2019) by Pharmaq Analytic (Fig. S2).
Cataracts (yes/no) were identified in April 2017 by
visual observation of both eyes, and losers (yes/no)
were identified subjectively in April 2017 based on
external appearance (i.e. losers being notably small
and thin, i.e. emaciated). In April 2017, a sub-sample
of fish (n = 80) from the vaccinated and unvaccinated
60 and 100% O2 saturation groups (n = 10 group−1) were
terminally anaesthetised and frozen for later radiolog-
ical assessment of the vertebral column. Levels of sex-
ual maturation, based on external morphology (see
Fjelldal et al. 2018), were assessed throughout. Mature
male post-smolts were identified by running milt,
whereas females showed no sign of maturity based on
the relative size of the gonopore. At the end of the
study, all remaining fish were terminally anaesthetised
and sexed by visual examination of the gonads.
The condition factor (CF) was calculated as CF =
weight (g) / length3 (cm) × 100. Specific growth rate
(SGR,% d–1) was calculated from the formula: SGR =
(eq − 1) × 100 (Houde & Scheckter 1981), where q =
[In(W2) − In(W1)] (t2 − t1)−1 (Bagenal & Tesch 1978) and
where W2 and W1 were the live body weights in
grams at times t2 and t1, respectively. The thermal
growth coefficient (TGC) was also calculated as
TGC = (W21/3 − W11/3) / (temperature [°C] × number
of days) × 1000 (Cho 1992).
2.3.  Radiology
Frozen fish were thawed and filleted to remove sur-
rounding flesh around the vertebral column to in -
crease the quality of the radiograph images. The ver-
tebral columns were radiographed (Porta 100 HF;
Eickemeyer Medizintechnik für Tierärzte) using a
35 × 43 cm image plate in a rigid cassette (Dürr Med-
ical) with 40 kV and 10 mAs at a distance of 70 cm.
The image plate was scanned (CR 35 VET; Dürr
Medical) and the resulting image converted into a
TIFF file (Vet-Exam Plus Software, version 4.14.0).
Evaluation of vertebral deformities was done accord-
ing to the classification of Witten et al. (2009).
2.4.  Antibody assay
Enzyme-linked immunosorbent assay (ELISA) was
used to determine the antibody titre in Atlantic salmon
sera against one of the vaccine antigens, Aeromonas
salmonicida subsp. salmonicida. Microtitre plates
(96-well Nunc MaxiSorp, ThermoFischer Scientific)
were coated overnight with A. salmonicida antigen
(4.8 × 106 cells well−1) and blocked for 1 h at 20°C
with phosphate buffered saline (PBS) (Sigma Aldrich)
with 1% bovine serum albumin (BSA). Serum was
diluted with PBS with 1% BSA in initial dilutions of
1:100, 1:400, 1:800, or 1: 1600, at Weeks 2, 4, 6, and
28, respectively. The samples were serially diluted by
2-fold dilution and incubated overnight between −2
and −8°C. Each plate included a positive and nega-
tive control serum (obtained from vaccinated and un -
vaccinated salmon). After incubation, microtitre plates
were washed 3 times (250 μl well−1) with PBS and
Tween (polysorbate) 20 (PBS-Tw) (Merck Millipore)
in an ELISA microplate washer (ELx405, BioTek).
Rabbit-anti-salmon antibodies were used as second-
ary antibody (2°Ab) and, along with the conjugate
(mouse-anti-rabbit HRP), were provided by Intervet
International Boxmeer. The 2°Ab and the conjugate
were diluted at 1:12 000 and 1:16 000, respectively.
After incubation with the 2°Ab, the plates were
washed 3 times using PBS-Tw. Plates were washed
6 times with PBS-Tw after incubation with the con -
jugate. The colour substrate 3,3’,5,5’-tetramethyl -
benzidine was diluted 1:60 with distilled water and
ureum-peroxide buffer (Intervet International) before
transferring 100 μl into each well. The reaction was
stopped after 20 min by adding 50 μl of sulphuric acid
(4 NH2SO4) into each well. Absorbance was read
using a microplate reader (Sunrise, Tecan Group) at
450 nm. The raw data were imported into the analy-
sis software CBA AbendVertical V1.21 (MSD, Propri-
etary Software) to calculate the antibody titres. The
mean negative control value × 5 was used to set the
threshold for calculating the antibody titres of the
sampled sera, which were expressed in log2, as the
maximum dilution corresponding to this threshold.
2.5.  Statistical analyses
The data were transferred to R version 3.6.0 (R
Development Core Team, www.r-project.org). Signif-
icance was assigned at p < 0.05. All raw data can be
found in Supplement 3 at www. int-res. com/ articles/
suppl/ q012 p327 _ supp/ (see tabs ‘Growth’, ‘Preva-
lences’, and ‘Immunity’) and the R script (Supple-
ment 2) used to analyse the data. The data from 126
fish were removed from the analysis due to duplicate
or triplicate PIT tag numbers (ranging from 1−27 vac-
cine−1 temperature−1 O2 saturation−1).
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We compared models that either supported or re -
jected our hypothesis using the Bayesian information
criterion (BIC). Two models were generated: (1) water
temperature (12/17°C) × O2 saturation (60/70/ 80/
100%, categorical) × vaccination (yes/no) + sex (male/
female); and (2) water temperature × O2 saturation +
vaccination + sex (male/female). The first model pro-
vides evidence that vaccine side-effects are depend-
ent on metabolic demand, whereas the second model
lends support to vaccine side-effects being independ-
ent of metabolic demands. Each time point was ana-
lysed separately, as we know time effects exist for the
effects of water temperature on long-term growth
(Grini et al. 2011), but there are no data on how O2
saturation and water temperature interact, and a 4-
way interaction (i.e. water temperature × O2 satura-
tion × vaccination × time) was rejected due to com-
plexity. We also controlled for sex due to its influence
on body size even in immature fish (Fraser et al.
2014). The model with the lowest BIC score was con-
sidered the ‘true’ model (Aho et al. 2014). Type II
sums of squares were used for models without inter-
actions, whereas main effects were calculated using
type III sums of squares when interactions were pres-
ent within the final model. Post hoc tests were done
using least square means with a Tukey adjustment
from the ‘emmeans’ library, whereby means for groups
are adjusted for means of other factors within the
model (Lenth 2016). The same model was used for
SGR, but the body weight at the start of the investi-
gated period was included as a main effect to control
for differences in initial body size, as smaller fish tend
to have higher growth rates (i.e. water temperature ×
O2 saturation × vaccination + start mass + sex). Mod-
els for TGC are included in Supplement 2, but mirror
the results of SGR and so are not presented.
To assess the prevalence of cataracts, we used the
exact binomial test using the ‘binom.test’ command.
To compare O2 saturation, multiple comparisons were
made (60 vs. 100%, 70 vs. 100%, 80 vs. 100%); there-
fore, a Bonferroni correction was made with signifi-
cance assigned at p < 0.017.
To determine whether antibody response could be
affected by environmental conditions, we used gen-
eralised least square models. Both temperature
(Eggset et al. 1997), O2 saturation (Kvamme et al.
2013), and their interaction (Niklasson et al. 2011)
influence the immune response in fish, whereas anti-
body production initially increases before reaching a
plateau over time (Eggset et al. 1997). Therefore, we
compared an initial model of water temperature × O2
saturation × time (week 2/4/6/28 post vaccination,
categorical) with a second model of water tempera-
ture × time + O2 saturation × time. The models were
corrected with the ‘weights=varPower()’ command to
correct for heteroskedasticity within the model resid-
uals. For these models, only data from vaccinated fish
were included, as unvaccinated fish from all groups
showed low levels of antibody titres throughout
(<6.6 titre; data not shown, but can be found in
 Supplement 3).
Due to an interest in the occurrence of losers, we
included models to assess their relative performance
compared to ‘normal’ fish, i.e. immature fish without
cataracts. Here, as expected (e.g. Fjelldal et al. 2011,
Imsland et al. 2014, Fraser et al. 2019a), exploratory
statistics demonstrated that males that matured as
post-smolts were heavier in November 2016, but
smaller in April 2017, compared to immature males
(Fig. S3A). Also, as expected (e.g. Bjerkås et al. 2001),
fish with cataracts became smaller from November
2016 onwards compared to fish without cataracts
(Fig. S3B). Therefore, these fish were not included
when assessing the performance of losers. For losers,
we used data from the 17°C and 60% O2 saturation
groups only, as this is where 87% (13 of 15) of the los-
ers were observed. Two initial linear mixed effect
(LME) models were produced to explore body mass
and body condition: (1) loser (yes/no) × time (October
2016/November 2016/April 2017, categorical) + sex
(male/female) + vaccination (yes/no); and (2) loser +
time + sex + vaccination. The first model provided
evidence that losers show transient growth effects
over time, whereas the second model demonstrated
that any loser effect was independent of time. In
these last 2 models, fish ID was included as a random
effect to account for repeated sampling of the same
individuals. In addition, only fish for which data were
available at all time points were included.
All model residuals were checked for normality fol-
lowing visual examination of q−q plots, and the
model accuracy was checked using standardised
residuals vs. fitted residual plots. If the model residu-
als failed to meet normality, the data were trans-
formed using either natural log transformation (body
mass in October 2016 and November 2016, body
mass for losers, maturity, and cataract models), the
‘weights=varPower()’ to correct for heteroskedastic-
ity (blood titres), or Tukey’s ladder of powers (body
mass in April 2017, SGR in April 2017) using the
‘transformTukey’ command from the ‘rcompanion’
library that finds the power transformation that makes
the data fit the normal distribution as closely as pos-
sible. All models that included transformations gave
results similar to models without transformations (see
Supplement 2 for details). For models that assessed
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growth over time, only those fish with data available
from every time point were analysed.
3.  RESULTS
3.1.  Mortality
Total mortality was <6% in all groups at termina-
tion of the experiment (Fig. S4). Mortality prior to
transfer to the sea-cage was low (<1% in any one
group) and could not be analysed statistically. There
was no general effect of vaccination or O2 saturation,
but the fish reared at 12°C had significantly lower
mortality than those reared at 17°C.
3.2.  Effects of vaccination on growth during
controlled environmental conditions
Vaccinated fish were significantly smaller than their
unvaccinated counterparts (Fig. 2A) due to re duced
growth rates (Fig. 2B), irrespective of environmental
treatment. Those fish kept on 60% O2 saturation were
significantly smaller than all other groups at 17°C, but
not at 12°C (Fig. 2A). However, there was a generally
positive association between growth rates and hy-
poxia that was more apparent at 17°C compared to
12°C (Fig. 2B). There was no interaction between vac-
cination and environmental conditions, as the models
that included the interaction had consistently higher
BIC scores than those without (No vember 2016 −
body mass, −742 vs. −780 and SGR, 371 vs. 339 for the
interaction and no inter action, respectively).
3.3.  Effects of vaccination and historic
 environmental conditions on growth under 
natural uncontrolled conditions
Vaccinated fish were still significantly smaller fol-
lowing 5 mo of common garden conditions than un -
vaccinated fish (Fig. 2C), but they had significantly
higher growth rates during this period (Fig. 2D). Fish
previously exposed to hypoxia at 17°C had signifi-
cantly lower growth rates than fish previously kept
on 100% O2 saturation (Fig. 2D), resulting in these
fish being significantly smaller at the end of the trial
(Fig. 2C). Fish previously reared at 12°C showed no
hypoxia effect on long-term growth. However, there
was no interaction between vaccination and historic
environmental conditions, as the models that in cluded
the interaction had consistently higher BIC scores
than those without (April 2017 body mass, 22 015 vs.
21 981 and SGR, 9639 vs. 9596 for the interaction and
no interaction, respectively). The effects of vaccina-
tion and environmental conditions on growth were not
explained by group differences in the levels of sexual
maturation and/or cataracts (data not shown, but the
models are provided in Supplement 2).
3.4.  Production parameters
Sexually mature fish, losers, and those with cataracts
were only found in groups that experienced 17°C
(Fig. 3). There was no effect of vaccination on the
prevalence of mature fish, but there was a non-signif-
icant trend for decreasing levels of sexual maturation
with lower O2 saturation in the 17°C fish (Fig. 3A).
Cataract prevalence was significantly higher in un -
vaccinated compared to vaccinated fish (Fig. 3B). Los-
ers were almost exclusively found among fish reared
on 60% O2 saturation, irrespective of the vaccination
status (Fig. 3C). There was no effect of vaccination or
O2 saturation on skeletal deformities, as only 2 out of
the 80 radiographed fish had any de formed vertebrae.
Both of these fish were previously reared on 60% O2
saturation at 17°C, 1 vaccinated (2 de formed verte-
brae) and 1 unvaccinated (15 de formed vertebrae).
3.5.  Antibody production
There was no interaction between temperature and
O2 saturation on antibody titres over time. However,
those fish vaccinated at 17°C had significantly higher
antibody titres at Weeks 2, 4, and 6 post-vaccination
when under control environmental conditions, but
not in April 2017 after 5 mo in natural uncontrolled
conditions (28 wk post-vaccination), compared to
those vaccinated at 12°C (Fig. 4A). In addition, the
interaction between O2 saturation and time was close
to significant, as the fish vaccinated at 60% O2 satu-
ration had significantly lower antibody titres than
those vaccinated at 100% O2 saturation in April 2017,
but not at Weeks 2, 4, and 6 post-vaccination (Fig. 4B).
3.6.  Losers
Based on the subjective assessment, losers were
found to be exclusively the smallest fish in April 2017
(no overlap with ‘normal’ fish, with the minimum
value for 'normal' fish being 150 g and the maximum
value for losers being 128 g), with a CF of <0.94 that
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Fig. 2. Body mass and growth data over time for vaccinated and unvaccinated Atlantic salmon reared under different con-
trolled conditions of temperature and oxygen (O2) saturation between 10 October and 30 November 2016 before common-
 garden rearing in uncontrolled environmental conditions within a sea-cage. (A) Body mass on 30 November 2016, (B) specific
growth rate (SGR) between 10 October and 30 November 2016, (C) body mass on 26 April 2017, and (D) SGR between 30 No-
vember 2016 and 26 April 2017. Data are means ± 95% CI (n = 67−89 group−1 time−1). The results from linear mixed effect mod-
els are presented for each time point. Different lowercase letters indicate significant O2 saturation effects at 12°C whereas 
uppercase letters indicate significant O2 saturation effects at 17°C (post hoc, least square means, p < 0.05)
Fig. 3. Percentage of Atlantic salmon that (A) sexually matured as post-smolts, (B) had cataracts, and (C) were ‘losers’. The sta-
tistics are from binomial tests of specific parameters. Data are (A) % of males only (n = 34−47 group−1) and (B,C) % of the whole
population (n = 96−122 group−1). Groups on the x-axis are categorised by vaccination status (UV: unvaccinated, V: vaccinated)− 
temperature (12 or 17°C)−O2 saturation (60, 70, 80, 100%)
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showed some overlap with normal fish (6 of the 1354
‘normal’ fish had a CF <0.94, but these 6 fish all
weighed >290 g). In all instances, the models for
body mass and body condition that included an inter-
action between losers and time had a lower BIC score
than the model without the interaction (body mass,
−158 vs. 35; body condition, −955 vs. −933 for models
with and without the interaction, respectively), pro-
viding evidence that loser effects are transient over
time. Subsequent analysis showed that losers were
equal in body mass and condition compared to ‘nor-
mal’ fish in October 2016, equal in body mass but
with a lower condition in November 2016, but had
significantly lower mean body mass and condition in
April 2017 (Fig. 5).
4.  DISCUSSION
We investigated whether growth following vacci-
nation was associated with environmental conditions
expected to alter or limit metabolic rate and found no
support for our hypothesis that vaccination leads to
an increase in metabolic demand, resulting in reduced
growth. However, we observed long-term effects on
growth relating to short-term hypoxia treatment fol-
lowing co-treatment at 17°C, but not 12°C.
Environmental conditions were manipulated for
7 wk post vaccination to see whether they influenced
vaccine-reduced growth. Based on cyclic hypoxia stud-
ies, we expected 60% O2 saturation at 17°C to be the
most challenging condition (Remen et al. 2012, 2013).
Indeed, the fish reared at 17°C and 60% O2 saturation
showed a significant reduction in growth and body
size at the end of the controlled environmental period
334
Fig. 4. Effect of (A) water temperature and (B) oxygen satu-
ration at vaccination on antibody titres over time in vacci-
nated Atlantic salmon. The results from linear models are
presented. Data are means ± 95% CI (n = 20 group−1 time−1).
Asterisks indicate a significant effect of temperature/O2
 saturation within a given time point (post hoc, least square 
means, *p < 0.05, ***p < 0.001)
Fig. 5. Body mass and condition of Atlantic salmon reared at
17°C and 60% O2 saturation for 7 wk followed by a further
28 wk in a sea-cage. (A) Body mass and (B) body condition
for ‘losers’ and control individuals over time. Data include
means ± 95% CI (n = 13−140 group−1 time−1). Asterisks indi-
cate a significant loser effect within a given time point (post
hoc, least square means, **p < 0.01), ***p < 0.001
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compared to those at 100% O2 saturation, but the
same hypoxia effect was not seen in 12°C fish. A level
of around 39% O2 saturation is expected to be physio-
logically challenging to salmon at 12°C (Remen et al.
2013). However, neither water temperature nor O2
saturation interacted with vaccination, suggesting
that direct costs to metabolism do not explain the re-
ductions in growth observed following vaccination.
Although theorised to be energetically costly, the di-
rect metabolic cost of mounting an immune response
is generally difficult to demonstrate, and studies in
rainbow trout have shown inconsistent results. For ex-
ample, vaccines without ad juvant have not led to sig-
nificant increases in metabolic rate (Ackerman et al.
2000, Skinner et al. 2010, Zanuzzo et al. 2015). How-
ever, antigens combined with adjuvants have led to
instances of increased metabolic rate (Skinner et al.
2010), although the effect is probably dependent on
the type of adjuvant and antigens included in the for-
mulation (Ackerman et al. 2000). In those instances
where the standard metabolic rate did increase after
exposure to adjuvanted vaccines, there was no sub-
sequent reduction in growth (Ackerman et al. 2000,
Skinner et al. 2010). Although we did not measure
standard metabolic rate in the current study, in a par-
allel study using the same vaccine and fish stock,
there was no effect of vaccination on routine metabolic
rate in an experiment lasting 30 d post vaccination, al-
though vaccinated fish grew more slowly (Torgersen et
al. 2017). Taken together, we found no evidence to
support the hypothesis that our vaccine re duced growth
due to an increase in metabolic demand in salmon.
A number of mechanisms could have disguised the
metabolic cost of vaccination. Firstly, fish were fed
throughout the study, and feeding has a metabolic
burden. Therefore, feed intake could be adjusted in
response to vaccination. Although we are unable to
address this in the current study, as vaccinated and
unvaccinated fish shared the same tanks, previous
studies have shown that short-term reductions in
feed intake following vaccination in salmon can lead
to a 20% reduction in growth 32 d post vaccination
(Sørum & Damsgård 2004). The cause of reduced
feeding may be related to vaccine-induced peritoni-
tis reducing short-term feeding/appetite (Bjørge et
al. 2011). Alternatively, vaccinated fish could have
re duced the extent of the immune response under
more demanding environmental conditions to con-
serve energy. Here, we found that antibody titres
were responsive to water temperature and O2 satura-
tion, but the effects were not those expected if meta -
bolism was restricting the antibody response. For
example, the 17°C fish showed a more rapid antibody
response than those vaccinated at 12°C, and the effect
of O2 saturation was not apparent during the period
of controlled environmental conditions when the fish
were actually experiencing hypoxia, it only occurred
later once the fish were transferred to common-garden
rearing with uncontrolled environmental conditions.
We found effects of both water temperature and O2
saturation on the antibody response that is in line
with previous studies. For example, salmon vacci-
nated against Vibrio salmonicida at 2°C showed a
delayed or suppressed antibody response compared
to salmon vaccinated at 10°C (Eggset et al. 1997),
similar to our current finding of a quicker antibody
response at 17 vs. 12°C. Regarding hypoxia, a study
in Nile tilapia Oreochromis niloticus vaccinated
against V. anguillarum found that 55% O2 saturation
reduced and delayed the antibody response com-
pared to 85% O2 saturation (Gallage et al. 2016), sim-
ilar to the results in the current work. In addition,
Atlantic salmon experiencing cyclic hypoxia, be tween
44 and 65% O2 saturation, had a 38−56% reduction
in head kidney leucocyte respiratory burst activity
compared to those on normoxia (Burt et al. 2013).
However, it should be noted that the lower antibody
levels in the 60 vs. 100% O2 saturation groups in this
study were not apparent during the initial 6 wk
period of controlled environmental conditions, but
came later when the fish were all common-garden
reared with uncontrolled environmental conditions.
Further work is required to determine whether this is
a genuine suppression of the immune system or a
delay in the antibody peak.
The growth difference between vaccinated and
unvaccinated fish occurred within the initial 7 wk
period of controlled environmental conditions and
remained evident at the end of the trial. However,
the vaccinated fish displayed some ‘catch-up’ growth
when reared for 5 mo under uncontrolled natural
conditions. This may suggest that a short-term reduc-
tion in feed intake is the main cause of the growth
disparity caused by vaccination (Sørum & Damsgård
2004). In contrast, those fish that experienced 60% O2
saturation and 17°C showed a chronic reduction in
growth rates that persisted even after 5 mo in com-
mon garden conditions, suggesting that a different
mechanism is operating on growth compared to the
vaccine effect, especially as there was no additive ef -
fect between O2 saturation and vaccination. Of note,
we cannot attribute the vaccine effect on growth to
the occurrence of skeletal deformities. Previously, in
some instances, vaccination has been found to lead
to an increase in skeletal deformity prevalence (e.g.
Berg et al. 2006) that is known to reduce growth
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(Hansen et al. 2010). However, we found no vaccine
effect on deformities after 120 d in seawater, similar
to other studies (e.g. Fraser et a. 2014).
O2 saturation during the period of controlled envi-
ronmental conditions had long-term effects on growth
in fish that initially experienced 17°C. Five months
post hypoxia exposure, the 60, 70, and 80% O2 satura-
tion groups were 26, 10, and 7% smaller, respectively,
than those that experienced 100% O2 saturation. The
reduction in growth during hypoxia is expected to be
related to lower feed intake as a mechanism to lower
metabolic demands under challenging conditions
(Remen et al. 2012). Previously, salmon exposed to
60% O2 at 16°C showed a 6% reduction in feed intake
and growth rates during the hypoxia exposures, but
showed compensatory growth after the cessation of
cyclic hypoxia treatment (Remen et al. 2014). We
report no evidence for compensatory growth 5 mo
post hypoxia treatment. Indeed, the drop-off in growth
between the 17°C and ≤80 and 100% O2 saturation
groups increased post hypoxia exposure. As there
was no drop-off in growth in those fish that experi-
enced low O2 saturation at 12°C, hypoxia alone is
unlikely to explain the current findings. Given that
the metabolically challenging conditions of 17°C and
60−70% O2 saturation were experienced during the
parr−smolt transformation, a process that is essential
for the long-term growth performance of the fish
(Björnsson et al. 2011), it may be that this develop-
mental process has been hindered in some aspect,
although we found no treatment effect on gill mark-
ers of smoltification. Further work into the long-term
effects of hypoxia and water temperature during the
parr−smolt transformation would be of interest.
We observed a positive association between water
temperature during the 7 wk of controlled environ-
mental conditions and sexual maturation and cataracts,
but no effect on skeletal deformities. The tempera-
ture effect on sexual maturation has been observed
previously (Fjelldal et al. 2011, Imsland et al. 2014).
The current 7 wk exposure to 17°C during smoltifica-
tion resulted in fully mature males out-of-season in
April 2017, as previously observed by Fjelldal et al.
(2011). We also note a trend for reduced prevalence
of sexual maturation in the 17°C/60% O2 saturation
group (Fig. 3A), suggesting that this temperature
effect may be related to growth acceleration, but this
requires further experimentation. Similarly, cataracts
were more prevalent in the fastest-growing groups
around sea transfer, unvaccinated fish kept at 17°C,
which conforms with the current literature (Bjerkås
et al. 2001) and would suggest growth rate during
a critical developmental window is a risk factor for
cataract development. Previously, salmon exposed to
16°C around smoltification have been found to have
an increased prevalence of skeletal deformities (Grini
et al. 2011, Fraser et al. 2019b). In the current work,
we found that deformities were few and could not be
linked to temperature or oxygen saturation around
smoltification. The inconsistency may be explained
by the length of the study. For example, in the study
by Fraser et al. (2019b), temperature treatments
around smoltification increased skeletal deformity
prevalence at harvest size after 533 d in seawater,
whereas no effects were observed at sea transfer or
following 120 d in seawater.
Losers were mainly found among fish reared at
60% O2 saturation at 17°C. To date, there is very little
information on losers (Stien et al. 2013), although
they are a concern for the industry with respect to
reduced animal welfare (Vindas et al. 2016) and eco-
nomic loss. We found that biometric data could not be
used to identify losers in October, but a minor reduction
in growth could be detected as early as November
before the more dramatic decrease in performance
following sea transfer. Further research is re quired to
understand the contributing factors to this condition.
However, as losers were most apparent under the
most challenging environment, the 7 wk period of
high water temperature and low O2 saturation, one
may suspect that the losers in the current study may
be individuals that could not tolerate physiologically
demanding environmental conditions. As the growth
of losers was already impaired in No vember 2016,
this could indicate a disruption of physiology during
the parr− smolt transformation that may then have led
to the more substantial negative effects on growth
upon entering the seawater environment. Alterna-
tively, it would also be of interest to screen for in -
fectious agents, as fish may be at an increased risk
of infection when environmental conditions are un -
favour able, such as during high water temperature
and periods of hypoxia (Bowden 2008). However, fur-
ther work in this area is required.
To conclude, there was no interaction between
environmental conditions expected to alter metabolic
rate and vaccine-induced growth reduction. There-
fore, the reduced growth observed following vacci-
nation is unlikely to be related to alterations in basal
metabolism.
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